Abbott Laboratories (ABT)
107.28
+2.01
(+1.91%)
USD |
NYSE |
Apr 19, 16:00
107.29
+0.01
(+0.01%)
After-Hours: 20:00
Abbott Laboratories Free Cash Flow: 5.059B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.059B |
| September 30, 2023 | 4.492B |
| June 30, 2023 | 5.488B |
| March 31, 2023 | 6.823B |
| December 31, 2022 | 7.804B |
| September 30, 2022 | 8.541B |
| June 30, 2022 | 8.468B |
| March 31, 2022 | 8.152B |
| December 31, 2021 | 8.648B |
| September 30, 2021 | 9.314B |
| June 30, 2021 | 8.644B |
| March 31, 2021 | 7.609B |
| December 31, 2020 | 5.724B |
| September 30, 2020 | 4.587B |
| June 30, 2020 | 4.564B |
| March 31, 2020 | 4.476B |
| December 31, 2019 | 4.498B |
| September 30, 2019 | 3.814B |
| June 30, 2019 | 4.096B |
| March 31, 2019 | 4.45B |
| December 31, 2018 | 4.906B |
| September 30, 2018 | 4.903B |
| June 30, 2018 | 4.816B |
| March 31, 2018 | 4.966B |
| December 31, 2017 | 4.435B |
| Date | Value |
|---|---|
| September 30, 2017 | 3.991B |
| June 30, 2017 | 3.154B |
| March 31, 2017 | 2.72B |
| December 31, 2016 | 2.082B |
| September 30, 2016 | 1.811B |
| June 30, 2016 | 1.69B |
| March 31, 2016 | 1.753B |
| December 31, 2015 | 1.856B |
| September 30, 2015 | 2.227B |
| June 30, 2015 | 2.367B |
| March 31, 2015 | 2.284B |
| December 31, 2014 | 2.598B |
| September 30, 2014 | 2.969B |
| June 30, 2014 | 2.29B |
| March 31, 2014 | 2.074B |
| December 31, 2013 | 2.179B |
| September 30, 2013 | 1.974B |
| June 30, 2013 | 4.718B |
| March 31, 2013 | 5.933B |
| December 31, 2012 | 7.519B |
| September 30, 2012 | 7.529B |
| June 30, 2012 | 7.143B |
| March 31, 2012 | 7.631B |
| December 31, 2011 | 7.479B |
| September 30, 2011 | 8.377B |
Free Cash Flow Range, Past 5 Years
3.814B
Minimum
Sep 2019
9.314B
Maximum
Sep 2021
6.358B
Average
5.724B
Median
Dec 2020
Free Cash Flow Benchmarks
| Boston Scientific Corp | 1.703B |
| Stryker Corp | 3.136B |
| Intuitive Surgical Inc | 749.60M |
| Insulet Corp | 36.50M |
| Edwards Lifesciences Corp | 629.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.038B |
| Cash from Investing (Quarterly) | -824.00M |
| Cash from Financing (Quarterly) | -2.052B |
| Free Cash Flow Per Share (Quarterly) | 1.308 |
| Free Cash Flow to Equity (Quarterly) | 3.132B |
| Free Cash Flow to Firm (Quarterly) | 2.345B |
| Free Cash Flow Yield | 2.70% |